The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: ritonavir     Quarter: 2016Q3

Total Drug/Injury Combinations: 268     Number of Pages: 14

DRUGNAME PT EventCount
RITONAVIR SOFT GELATIN CAPSULES Pre-eclampsia 1 view events
RITONAVIR SOFT GELATIN CAPSULES Pregnancy 1 view events
RITONAVIR SOFT GELATIN CAPSULES Premature rupture of membranes 1 view events
RITONAVIR SOFT GELATIN CAPSULES Transaminases increased 1 view events
RITONAVIR. Abdominal pain upper 1 view events
RITONAVIR. Acrochordon 1 view events
RITONAVIR. Anal abscess 1 view events
RITONAVIR. Anal atresia 1 view events
RITONAVIR. Anal haemorrhage 1 view events
RITONAVIR. Anal polyp 1 view events
RITONAVIR. Anxiety 1 view events
RITONAVIR. Appendicitis 1 view events
RITONAVIR. Back pain 1 view events
RITONAVIR. Basedow's disease 1 view events
RITONAVIR. Birth trauma 1 view events
RITONAVIR. Blood bilirubin increased 1 view events
RITONAVIR. Blood cortisol decreased 1 view events
RITONAVIR. Blood glucose decreased 1 view events
RITONAVIR. Blood glucose increased 1 view events
RITONAVIR. Blood HIV RNA increased 1 view events

Total Drug/Injury Combinations: 268     Number of Pages: 14

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)